Ishihara, Okayama
Minoru Ishihara, Okayama JP
Patent application number | Description | Published |
---|---|---|
20090078021 | Metal sheet pressing method - This invention provides a metal sheet pressing method of precision-pressing a metal sheet, wherein after a metal sheet ( | 03-26-2009 |
20100218584 | Metal sheet pressing method - This invention provides a metal sheet pressing method of precision-pressing a metal sheet, wherein after a metal sheet ( | 09-02-2010 |
20110265542 | METAL SHEET PRESSING METHOD - This invention provides a metal sheet pressing method of precision-pressing a metal sheet, wherein after a metal sheet ( | 11-03-2011 |
20120180544 | METAL SHEET PRESSING METHOD - This invention provides a metal sheet pressing method of precision-pressing a metal sheet, wherein after a metal sheet ( | 07-19-2012 |
Noriyuki Ishihara, Okayama JP
Patent application number | Description | Published |
---|---|---|
20100124663 | RESIN COMPOSITION AND SHEET USING RESIN COMPOSITION - A resin composition with no substantial halogen element content contains a tungsten powder, a polyester elastomer, silica, a polysiloxane compound, and melamine cyanurate. Relative to 100% in weight of the polyester elastomer, the total content of silica and the polysiloxane compound is 22% or more in weight, the content of melamine cyanurate is 17% or more in weight, and the total content of silica, the polysiloxane compound, and melamine cyanurate is 45% to 53% in weight. The oxygen index of the resin composition is 26 or more. The number of times of circumferentially bending a test piece at 90 degrees around a 10 mm-diameter column in a repetitive bending test using the test piece made of the resin composition having a length of 50 mm, a width of 100 mm, and a thickness of 2.25 mm is 1000 or more. | 05-20-2010 |
Takafumi Ishihara, Okayama JP
Patent application number | Description | Published |
---|---|---|
20080262217 | METHOD OF PHYSICOCHEMICALLY PRODUCING GLYCOGEN AND GLYCOGEN OBTAINED BY THE SAME - A method of producing glycogen is provided. The method comprises the step of heat- and pressure-treating a sugar-containing material under acidic conditions. The sugar-containing material is a polysaccharide or an oligosaccharide. Alternatively, the sugar-containing material is a plant material selected from the group consisting of Panax notoginseng, Yun Nan San-chi powder (trademark), Panax ginseng, wheat flour, soybean, soy flour, shiitake, and coffee extract residue. Representatively, the glycogen includes a molecule having a molecular weight of 10,000 or less. The glycogen has a specific rotation of [α] | 10-23-2008 |
20110065673 | NOVEL LEUKOTRIENE RECEPTOR AGONIST - It is an object of the present invention to provide a leukotriene receptor antagonist that can be conveniently prepared from a natural source. | 03-17-2011 |
20140005144 | NOVEL LEUKOTRIENE RECEPTOR ANTAGONIST | 01-02-2014 |
Tatsuya Ishihara, Okayama JP
Patent application number | Description | Published |
---|---|---|
20130165399 | THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, CONTAINING ADENOSINE N1-OXIDE AS AN EFFECTIVE INGREDIENT - The present invention has an object to provide an effective and safe therapeutic agent for inflammatory diseases such as sepsis, hepatitis, and inflammatory bowel disease, and solves the above object by providing a therapeutic agent for inflammatory diseases containing adenosine N1-oxide or a derivative thereof as an effective ingredient. | 06-27-2013 |
20130309188 | EXTERNAL PREPARATION FOR SKIN - The present invention has an object to provide an external dermal agent with a sustainable anti-wrinkle action, which has both the action of enhancing the proliferation and differentiation of keratinocytes in the skin and the action of enhancing the collagen production in the skin, and which assists the maintenance and the improvement of tissue structures and physiological functions of the epidermis and the dermis, whereby providing a remarkable skin improvement effect. The present invention solves the above abject by providing an external dermal agent containing α-D-glucopyranosyl-(1→3′)-adenosine and/or α-D-glucopyranosyl-(1→5′)-adenosine as an effective ingredient(s). | 11-21-2013 |
20140315849 | THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, CONTAINING ADENOSINE N1-OXIDE AS AN EFFECTIVE INGREDIENT - The present invention has an object to provide an effective and safe therapeutic agent for inflammatory diseases such as sepsis, hepatitis, and inflammatory bowel disease, and solves the above object by providing a therapeutic agent for inflammatory diseases containing adenosine N1-oxide or a derivative thereof as an effective ingredient. | 10-23-2014 |